help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strange, C.
Right arrow Articles by Idell, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strange, C.
Right arrow Articles by Idell, S.

Am. J. Respir. Crit. Care Med., Vol 151, No. 2, 02 1995, 508-515.

Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease

C Strange, MH Baumann, SA Sahn and S Idell
Department of Medicine, Medical University of South Carolina, Charleston 29425.

Extravascular fibrin deposition is common at sites of pleural injury and has been related to loculation of pleural fluids. Although thrombolytic therapy has been used to treat pleural loculations, it has not been compared with pleural administration of anticoagulant therapy. We therefore tested interventional strategies designed to compare the relative effects of in vivo anticoagulation or supplemented fibrinolysis on pleural injury, and to characterize the local tissue responses to these modalities. Early intrapleural instillation of saline (Group 1), heparin 1,000 IU (Group 2), or urokinase (uPA) 1,500 IU (Group 3) every 12 h for 3 d was used to interrupt pleural adhesion formation and pleural fibrosis induced by tetracycline hydrochloride in rabbits. Procoagulant and fibrinolytic activities were determined in pleural effusion samples obtained serially every 12 h after the last administered intrapleural dose. Pleural fluid procoagulant activity was blocked by intrapleural heparin (p < 0.001), but plasminogen-dependent fibrinolytic activity was rarely increased by intrapleural urokinase. Most plasminogen activator activity in the pleural fluids was found at high-molecular-weight regions by enzymography, suggesting that it was bound to inhibitor(s). Pathologic analysis at 14 d demonstrated that the number of pleural adhesions in the heparin (8.4 +/- 3.4, mean +/- standard error) and uPA groups (6.1 +/- 2.5) was less than in saline- treated tetracycline controls (20.7 +/- 4.7) (both p < 0.02). Visceral pleural thickness did not differ between groups (p = NS). We conclude that intrapleural heparin or uPA are equally effective in decreasing intrapleural adhesions in tetracycline-induced pleural injury. The data indicate that early anticoagulation or fibrinolytic intervention can attenuate subsequent pleural symphysis in this model.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Idell, T. Allen, S. Chen, K. Koenig, A. Mazar, and A. Azghani
Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L25 - L32.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
V. Getman, E. Devyatko, E. Wolner, S. Aharinejad, and M. R. Mueller
Fleece bound sealing prevents pleural adhesions
Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 243 - 246.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Erkan, S. Fyndyk, O. Uzun, A. G. Atycy, and R. W. Light
A New Radiologic Appearance of Pulmonary Thromboembolism: Multiloculated Pleural Effusions
Chest, July 1, 2004; 126(1): 298 - 302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Chuang-Tsai, T. H. Sisson, N. Hattori, C. G. Tsai, N. M. Subbotina, K. E. Hanson, and R. H. Simon
Reduction in Fibrotic Tissue Formation in Mice Genetically Deficient in Plasminogen Activator Inhibitor-1
Am. J. Pathol., August 1, 2003; 163(2): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. B. Antony
Fibrinolysis in the Pleural Space: Breaking the Bonds That Bind
Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 909 - 910.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Idell, A. Mazar, D. Cines, A. Kuo, G. Parry, S. Gawlak, J. Juarez, K. Koenig, A. Azghani, W. Hadden, et al.
Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits
Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 920 - 926.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. IDELL, A. P. MAZAR, P. BITTERMAN, S. MOHLA, and A. L. HARABIN
Fibrin Turnover in Lung Inflammation and Neoplasia
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 578 - 584.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. BOUROS, S. SCHIZA, N. TZANAKIS, G. CHALKIADAKIS, J. DROSITIS, and N. SIAFAKAS
Intrapleural Urokinase versus Normal Saline in the Treatment of Complicated Parapneumonic Effusions and Empyema . A Randomized, Double-Blind Study
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 37 - 42.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society